Hernández-Herrera RJ, Rojas-Patlán L, Garza-Pérez RM, Dávila-Rodríguez M, Cortés-Gutiérrez EI, García-Rodríguez EO, Hernández-Hernández RR

Language: Spanish
References: 9
Page: 90-93
PDF size: 47.72 Kb.

ABSTRACT

Background: chromosomal abnormalities are present in 2-4 % of all newborns, and they cause 20 % of deaths in the fi rst year of life. The estimated prevalence of chromosomal abnormalities is one for each 500- 1000 newborns. These abnormalities can be numerical or structural, and they can affect autosomal or sexual chromosomes. They affect from 1 to 3 % of general population, and from 6 to 7 % of individuals with congenital anomalies.
Methods: descriptive study, which included all the registries of cytogenetic analysis (of adults and newborns) made in a genetic laboratory in a period of 14 years. The prevalence of polymorphisms and chromosomal abnormalities in the patients from the Hospital de Ginecoobstetricia 23, Instituto Mexicano del Seguro Social (Monterrey, Nuevo León) was assessed.
Results: of 4006 cytogenetic studies, 253 (6.3 %) did not show in vitro growth, 2667 (66.5 %) were normal, and 1175 (29.3 %) were abnormal. Of these, 614 (52.2 %) had polymorphisms, and 561 (47.7 %) structural or numerical chromosomal abnormalities. In regards to these chromosomopathies (561), trisomy 21 was observed in 429 (36.5 %); Turner’s syndrome, in 84 (7.1 %); trisomy 18, in 57 (4.8 %); and trisomy 13, in 32 (2.7 %). With G-band technique, we found 93 % of in vitro cell growth.
Conclusions: of these studies, 55 % was performed due to non-numerical abnormalities; 14.4 %, due to structural abnormalities; and the rest, due to polymorphisms.

REFERENCES

1. Guízar-Vázquez JJ, coordinador. Genética clínica: diagnóstico y manejo de las enfermedades hereditarias. Segunda edición. México: Manual Moderno; 1994.

2. Moore KL, Persuad TVN. Embriología clínica. Octava edición. Barcelona, España: Elsevier; 2008.

3. Hernández-Herrera RJ, Cerda-Flores RM, Dávila- Rodríguez MI, Cortés-Gutiérrez EI. Estimación de la tasa de incidencia de algunos defectos congénitos en Monterrey, México. Ginecol Obstet Mex. 2002;70:597-600.

4. Cortés-Gutiérrez EI, Cerda-Flores RM, Silva-Cudish JB, Hernández-Herrera RJ, Leal-Garza CH. Evaluation of sex chromosome aneuploidies in women with Turner’s syndrome by G-banding and FISH. A serial case study. J Reprod Med. 2003;48(10):804-8.

5. Zhu JL, Basso O, Obel C, Bille C, Olsen J. Infertility, infertility treatment, and congenital malformations: Danish national birth cohort. BMJ. 2006;333(7570):679. doi:10.1136/ bmj. 38919. 495718.AE.

6. Shah K, Sivapalan G, Gibbons N, Tempest H, Griffi n D. The genetic basis of infertility. Reproduction. 2003;126(1):13-25.

7. Cortés-Gutiérrez EI, Cerda-Flores RM, Dávila- Rodriguez MI, Hernández-Herrera RJ, Leal-Garza C. Chromosomal abnormalities and polymorphisms in Mexican infertile men. Arch Androl. 2004;50(4):261-5.

8. Herman A, Maymon R, Dreazen E, Caspi E, Bukovsky I, Weinraub Z. Nuchal translucency audit: a novel image-scoring method. Ultrasound Obstet Gynecol. 1998;12(6):398-403.

9. Clementini E, Palka C, Lezzi I, Stuppia L, Guanciali- Franchi P, Tiboni GM. Prevalence of chromosomal abnormalities in 2078 infertile couples referred for assisted reproductive techniques. Hum Reprod. 2005;20(2):437-42.